Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DXYN | US
0.03
3.80%
Consumer Cyclical
Textile Manufacturing
30/06/2024
19/09/2024
0.74
0.71
0.77
0.69
The Dixie Group Inc. manufactures markets and sells floorcovering products to residential customers in North America and internationally. The company offers residential carpets custom rugs and engineered wood products under the Fabrica brand for interior decorators and designers selected retailers and furniture stores luxury home builders and manufacturers of luxury motor coaches and yachts; and specialty carpets and rugs for the high-end residential marketplace as well as luxury vinyl flooring products and broadloom carpet products under the Masland Residential brand name through the interior design community and specialty floorcovering retailers. It also provides residential tufted broadloom carpets and rugs to selected retailers and home centers under the Dixie Home and private label brands as well as luxury vinyl flooring products to the marketplace it serves. The Dixie Group Inc. was founded in 1920 and is based in Dalton Georgia.
View LessValue Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
90.4%1 month
89.4%3 months
102.6%6 months
101.3%-
-
0.42
4.22
0.58
9.16
0.46
-1.07
7.17M
11.34M
11.34M
-
3.39
647.60
-4.70
-1.89
0.30
0.19
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.20
Range1M
0.31
Range3M
0.40
Rel. volume
0.50
Price X volume
21.67K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.06 | 11.47M | -59.49% | n/a | 5.20% |
Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 0.3412 | 8.07M | -4.16% | n/a | 13.87% |
Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 1.28 | 7.10M | -0.78% | n/a | 13.20% |
Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 2.15 | 4.80M | -4.02% | n/a | 222.75% |
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.83 | 3.93M | -10.93% | n/a | 8.44% |
Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 2.61 | 3.74M | -3.33% | 0.07 | 0.00% |
Evoke Pharma Inc | EVOK | Drug Manufacturers-Specialty & Generic | 4.44 | 3.64M | 4.72% | 0.04 | 187.62% |
SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 1.62 | 3.61M | -2.41% | n/a | 144.16% |
PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.3752 | 3.60M | 0.05% | n/a | 83.11% |
Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 1.151 | 2.99M | -2.46% | n/a | -104.44% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 9.16 | - | - |
Ent. to Revenue | 0.46 | - | - |
PE Ratio | - | - | - |
Price to Book | 0.42 | - | - |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 102.64 | - | - |
Debt to Equity | 4.22 | - | - |
Debt to Assets | 0.58 | - | - |
Market Cap | 11.34M | - | - |